semaglutide drug shortage The Wegovy Continues, Leaving Patients On the Weight Loss in Limbo Ozempic and Wegovy officially moved

If the cost of Mounjaro remains a limiting factor, you can consult a healthcare provider for potential Mounjaro alternatives that may be more affordable or covered by your plan

Diagnosis should be established comprehensively considering clinical, imaging, pathological, ultrastructure, immunohistochemical, and molecular characteristics

Key players include Novo Nordisk, Eli Lilly and Company, Pfizer, Amgen, AstraZeneca, Boehringer Ingelheim, Sanofi, Regeneron, Viking Therapeutics, Inc., and Terns Pharmaceuticals - competing across injectable, oral, and next-gen incretin-based therapies

The FDA has also warned consumers and medical staff, saying it has confirmed that fake products that mimic genuine Ozempic have actually been distributed

Study Used AI to Analyze Real-World Patient Reports To better understand how people experience GLP-1 drugs outside of clinical trials, researchers used AI to analyze Reddit posts from 2019 to 2025